stocksTRUALT
417.20-5.8 (-1.37%)
17 Jul, 12:00 AM

Income Statement

Abridged
Understanding Income Statement
TruAlt Bioenergy Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
PR
12M
PR
12M
PR
12M
PR
12M
PR
12M
PRESS
Total Revenue
5256967621,2231,9081,728
Cost of Operating Revenue
3895375839481,4351,201
Gross Profit
136158180276473527
Gross Margin
25.922.823.622.524.830.5
Total Operating Expenses
4326056781,0921,6651,524
Operating Profit
939184131242204
Operating Margin
17.813.111.110.712.711.8
Financing Income/(Expense) - Net
-27-41-35-93-84-160
Profit before Taxes
66504945159130
Income Taxes
171314131333
Profit after Tax
4938353214796
PAT Margin
9.45.44.72.67.75.6
EPS - Basic - ex Extraordinary Items
5.774.394.143.7117.1012.30
EPS - Diluted - ex Extraordinary Items
5.774.394.143.7117.1012.30
EBIT
939184131242204
EBITDA
100109105188309290
EBITDA Margin
19.015.613.815.416.216.8

Balance Sheet

Abridged
Understanding Balance Sheet
TruAlt Bioenergy Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Source:
PR
PR
PR
PR
PR
PRESS
Total Current Assets
2342604646581,0621,479
Long-Term Investments
-0--227
Property Plant & Equipment - Net
3396471,1581,4781,6902,125
Total Non-Current Assets
3789051,3921,7611,9682,300
Total Assets
6121,1651,8562,4193,0303,778
Total Current Liabilities
2083944431,0611,0471,085
Long Term Debt
3146321,0709801,122993
Total Non-Current Liabilities
3326611,1731,0931,2131,115
Total Liabilities
5401,0551,6152,1542,2612,200
Total Shareholders' Equity
721102402657691,520
Minority Interest
-----58
Total Equity
721102402657691,578
Total Liabilities & Equity
6121,1651,8562,4193,0303,778

Cash Flow

Abridged
Understanding Cash Flow Statement
TruAlt Bioenergy Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
PR
12M
PR
12M
PR
12M
PR
12M
PR
12M
PRESS
Operating CF bef Changes in Working Cap
72.5866.71100.61137.86161.05204.21
Working Capital - Increase/(Decrease)
-130.7065.64128.38-205.2628.81-653.52
Net CF from Operating Activities
-58.12132.34228.99-67.40189.87-449.30
Capital Expenditures - Net
55.37545.10275.54356.80259.70393.62
Net CF from Investing Activities
-59.13-551.18-1,148.58-383.67-242.53-419.80
Stock - Issuance/(Retirement) - Net
--61.01--665.71
Debt - LT & ST - Issuance/(Retirement) - Total
166.15366.54863.30469.63179.0994.97
Net Cash Flow from Financing Activities
166.14366.54924.31469.63179.09807.59
Free Cash Flow to Equity
52.65-46.21816.7445.43109.25-747.96
Free Operating CF net dividend
-113.49-412.76-46.55-424.20-69.83-959.99
Free Operating CF
-113.49-412.76-46.55-424.20-69.83-959.99

Business Segment Analysis

FY End:
Mar 25

TruAlt Bioenergy Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex
Total₹ 260Cr
biofuels producers (100.0%)₹ 259.70 Cr
Revenue / Sales
Total₹ 1,908Cr
biofuels producers (100.0%)₹ 1,907.72 Cr
Assets
Total₹ 3,030Cr
biofuels producers (100.0%)₹ 3,029.73 Cr
Operating Income
Total₹ 242Cr
biofuels producers (100.0%)₹ 242.32 Cr

Regional Segment Analysis

TruAlt Bioenergy Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for TruAlt Bioenergy Ltd.

Historical Segment Analysis

Track how TruAlt Bioenergy Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Business
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
biofuels producers55545276357260

Frequently Asked Questions

What is the revenue of TruAlt Bioenergy Ltd.?
The latest trailing twelve month revenue of TruAlt Bioenergy Ltd. is ₹ 1,727.51 Cr, reflecting a 1-year growth of -9.45% and a 3-year CAGR of 31.35%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of TruAlt Bioenergy Ltd.?
The latest trailing twelve month net profit (PAT) of TruAlt Bioenergy Ltd. is ₹ 96.87 Cr, with a 3-year earnings CAGR of 43.82%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of TruAlt Bioenergy Ltd.?
The trailing twelve month EBITDA of TruAlt Bioenergy Ltd. is approximately ₹ 203.53 Cr (based on an operating margin of 11.78%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of TruAlt Bioenergy Ltd.?
The trailing twelve month Earnings Per Share (EPS) of TruAlt Bioenergy Ltd. is 12.30. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of TruAlt Bioenergy Ltd.?
The debt-to-equity ratio of TruAlt Bioenergy Ltd. stands at 1.09. The interest coverage ratio is 1.27x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of TruAlt Bioenergy Ltd.?
The estimated book value per share of TruAlt Bioenergy Ltd. is 177.29 (derived from a P/B ratio of 2.35 and market price of ₹ 417.20), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of TruAlt Bioenergy Ltd.?
The trailing twelve month operating cash flow of TruAlt Bioenergy Ltd. is ₹ -15.30 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does TruAlt Bioenergy Ltd. report consolidated or standalone financials?
TruAlt Bioenergy Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.